TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been named a winner of the 2025 BSMA ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
Vietnam Investment Review on MSN1d
Alma introduces Alma Harmony, a state-of-the-art aesthetic platform for next-level in-office treatmentsFeaturing a simply intelligence interface and substantial technological upgrades, the new multiplatform presents a new era in patient personalization CAESAREA, Israel, March 26, 2025 /PRNewswire/ ...
In today's Morning Rounds newsletter, proposed cuts to cancer research under the Trump administration, a fake CDC page with ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other platforms.
Hunter Whitley always wanted to be a Marine. “That was his lifelong dream,” said Shannon McDaniel, Whitley’s mother. “We ...
Montrose Regional Health has been recognized as a recipient of the 2025 Patient Safety Excellence Award™ by Healthgrades, the ...
Alterity Therapeutics (ATHE) announced that the last patient in the ATH434-202 Phase 2 trial has completed the study. The ATH434-202 is an open ...
News Medical on MSN6h
Pharmacogenomic testing could help reduce adverse drug reactions in the UKA new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback